Hôpital Saint-Louis Implements SOPHiA DDM™ Platform to Further Research of Myeloid Disorders

/PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Hôpital Saint-Louis,...

Related Keywords

Switzerland ,Boston ,Massachusetts ,United States ,Turkey ,Paris ,France General ,France ,Bruno Cassinat ,Kevin Puylaert ,Nasdaq ,Linkedin ,Facebook ,Instagram ,Cellular Biology Department ,Myeloid Disorders ,Molecular Diagnostics ,Managing Director ,Vitro Diagnostic Use ,Sophia Genetics ,